Capitol Health Limited (AU:CAJ) has released an update.
Capitol Health Limited reports a robust financial year with a 12% increase in revenue to $234.8 million and a significant 22.6% rise in Operating EBITDA to $49.3 million, despite a statutory net loss after tax due to non-cash adjustments. The year also marked strategic growth with the acquisition of Future Medical Imaging Group and a proposed merger with Integral Diagnostics, aiming to create Australia’s largest pure-play publicly listed imaging company. The company anticipates the merger will finalize this year, enhancing value for shareholders and offering further growth and career opportunities.
For further insights into AU:CAJ stock, check out TipRanks’ Stock Analysis page.
